Quibim, a Spanish startup that’s growing foundational AI fashions for medical imaging spanning oncology, immunology, neurology, and metabolic problems, has raised $50 million in a Collection A spherical of funding.

The money injection comes as AI makes ever deeper inroads into healthcare, spanning the whole lot from drug discovery to clinical trials.

Quibim, for its half, is getting down to improve diagnostic accuracy and illness detection from visible information procured from X-rays, CT scans, and MRIs. The corporate’s flagship product, QP-Prostate, is designed to enhance prostate most cancers detection, with separate merchandise within the works for the brain, liver, breast, and lung.

Individually, Quibim additionally presents QP-Insights for processing multi-omics information (i.e. various kinds of organic information), for instance in scientific trials and associated research.

Quibim says its longer-term plan is to create digital twins of your complete human physique, serving “dynamic fashions” that assist the medical group higher perceive the human physique. That each one begins on the “organ and lesion degree,” as demonstrated by QP-Prostate.

Plans to develop within the U.S.

Valencia-based Quibim has now raised round $70 million since its inception, and with its newest funding, the corporate says it plans to double-down on its U.S. enlargement plans. Certainly, Quibim received FDA 510(k) clearance again in 2023 to market its QP-Prostate product; it additionally hired its first chief medical officer within the U.S.

On the time of writing, Quibim says it has 170 installations globally, with companions together with Stanford College and Harvard-affiliated built-in healthcare system Mass General Brigham. Individually, Philips previously announced plans to combine Quibim’s AI fashions into its scanners.

Quibim’s Collection A spherical was led by Spanish venture capital firm Asabys and personal fairness agency Buenavista, with participation from a slew of institutional and particular person buyers, together with: Amadeus Capital Companions, Apex Ventures, Partech, and iPod and iPhone co-creator Tony Fadell.

“Quibim’s mission is to show imaging right into a catalyst for precision well being,” Quibim CEO and co-founder Ángel Alberich-Bayarri stated in a press release. “Our world enlargement into the U.S. is a essential milestone as we work with pharmaceutical leaders and healthcare suppliers to unlock the facility of imaging to revolutionize diagnostics and enhance affected person outcomes.”